[go: up one dir, main page]

ATE250030T1 - Peptidverbindungen mit mmp- und tnf-hemmender wirkung - Google Patents

Peptidverbindungen mit mmp- und tnf-hemmender wirkung

Info

Publication number
ATE250030T1
ATE250030T1 AT97915607T AT97915607T ATE250030T1 AT E250030 T1 ATE250030 T1 AT E250030T1 AT 97915607 T AT97915607 T AT 97915607T AT 97915607 T AT97915607 T AT 97915607T AT E250030 T1 ATE250030 T1 AT E250030T1
Authority
AT
Austria
Prior art keywords
pct
compounds
mmp
subject invention
peptide compounds
Prior art date
Application number
AT97915607T
Other languages
English (en)
Inventor
Andrew Douglas Darwin D Baxter
Road Milton
David Alan Darwin Discove Owen
John Gary Darwin Disco Montana
Robert John Darwin Disc Watson
John Fraser Darwin Disco Keily
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ATE250030T1 publication Critical patent/ATE250030T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/32Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97915607T 1996-04-04 1997-04-04 Peptidverbindungen mit mmp- und tnf-hemmender wirkung ATE250030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607249.1A GB9607249D0 (en) 1996-04-04 1996-04-04 Compounds
PCT/GB1997/000959 WO1997037974A1 (en) 1996-04-04 1997-04-04 Peptidyl compounds having mmp and tnf inhibitory activity

Publications (1)

Publication Number Publication Date
ATE250030T1 true ATE250030T1 (de) 2003-10-15

Family

ID=10791700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97915607T ATE250030T1 (de) 1996-04-04 1997-04-04 Peptidverbindungen mit mmp- und tnf-hemmender wirkung

Country Status (9)

Country Link
US (1) US6090840A (de)
EP (1) EP0891329B1 (de)
JP (1) JP2000508640A (de)
AT (1) ATE250030T1 (de)
AU (1) AU713477B2 (de)
CA (1) CA2248070A1 (de)
DE (1) DE69724944T2 (de)
GB (1) GB9607249D0 (de)
WO (1) WO1997037974A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
FR2797890A1 (fr) * 1999-08-31 2001-03-02 Pf Medicament Nouvelle metalloprotease matricielle mmp-24 homologue aux stromelysines
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
PT2087908T (pt) 2001-06-26 2018-07-16 Amgen Inc Anticorpos contra opgl
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20100226922A1 (en) * 2006-06-08 2010-09-09 Dorothea Maetzel Specific protease inhibitors and their use in cancer therapy
EP3609877B1 (de) * 2017-04-14 2020-12-23 Cosma S.p.A. Verfahren zur herstellung von firocoxib

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds

Also Published As

Publication number Publication date
DE69724944D1 (de) 2003-10-23
AU713477B2 (en) 1999-12-02
EP0891329A1 (de) 1999-01-20
AU2302597A (en) 1997-10-29
CA2248070A1 (en) 1997-10-16
WO1997037974A1 (en) 1997-10-16
US6090840A (en) 2000-07-18
EP0891329B1 (de) 2003-09-17
JP2000508640A (ja) 2000-07-11
GB9607249D0 (en) 1996-06-12
DE69724944T2 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
FI961976A0 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
EP1119362A4 (de) Verwendungsmethode von tetracyclinverbindungen zur steigerung der interleukin-10 produktion
NZ335981A (en) Ketobenzamides as calpain inhibitors
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
NZ330287A (en) Substituted 1,4-benzodiazepine inhibitors of farnesyl protein transferase
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
MY130363A (en) "pyrrole substituted 2-indolinone protein kinase inhibitors"
EP1163208A4 (de) Caspase inhibitoren und deren verwendung
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
BG104899A (en) Antipicornaviral compounds and compositions, their pharmaceutical use and materials for their synthesis
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE250030T1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE309352T1 (de) Inhibitoren der nf-kb aktivierung
DE69724112D1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
SE9802538D0 (sv) New pharmaceutically active compounds
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE208202T1 (de) Verwendung von dimeticon zur behandlung der konstipation
ATE219668T1 (de) Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie
HUP9802142A2 (hu) Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties